Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03472040 · ClinicalTrials.gov registry record · Phase 2
A Long Term Safety Study of BCX7353 in Hereditary Angioedema
A Phase 2 study, sponsored by BioCryst Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 387
- Enrollment target
NCT03472040: Completed Phase 2 study, sponsored by BioCryst Pharmaceuticals.
NCT03472040 is a Phase 2 study that has completed, run by BioCryst Pharmaceuticals. The registered enrollment target is 387 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (191% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03472040, a Phase 2 study, has completed, sponsored by BioCryst Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 387 participants
- Enrollment target
Study Summary
This is an open-label study to evaluate the long term safety and effectiveness of oral treatment with BCX7353 in preventing acute angioedema attacks in patients with Type I and Type II Hereditary Angioedema (HAE).
Primary Outcome
The number and percentage of subjects with treatment-emergent adverse events.
Interventions
- DRUG BCX7353
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 387 participants |
| Start Date | 2018-02-16 |
| Est. Completion | 2022-04-27 |
| Phase | Phase 2 |
What the finished NCT03472040 record still lists
NCT03472040 is an interventional study that assigns participants to a tested intervention. The registered 387 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (191% higher).
The record links to 0 conditions, and to 1 intervention - of which BCX7353 is the first listed.
NCT03472040 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03472040 about?
NCT03472040 is a clinical study titled "A Long Term Safety Study of BCX7353 in Hereditary Angioedema". This is an open-label study to evaluate the long term safety and effectiveness of oral treatment with BCX7353 in preventing acute angioedema attacks in patients with Type I and Type II Hereditary Angioedema (HAE).
What is the current status of trial NCT03472040?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 387 participants. The study started on 2018-02-16. Estimated completion is 2022-04-27.
What interventions are being tested in trial NCT03472040?
The interventions under investigation include: BCX7353 (DRUG).
Who is sponsoring clinical trial NCT03472040?
This trial is sponsored by BioCryst Pharmaceuticals, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03472040's enrollment target sits among peer trials
387 109th of 2000 higher than 1,892 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03761108 · 387 participants · Phase 1
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
- NCT05572632 · 387 participants · NA
Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
- NCT06917079 · 387 participants · Phase 1
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- NCT04092010 · 388 participants · NA
Improving Preschool Outcomes by Addressing Maternal Depression in Head Start
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI